Home/Filings/4/0001209191-22-053710
4//SEC Filing

Ndu Adora 4

Accession 0001209191-22-053710

CIK 0001070494other

Filed

Oct 13, 8:00 PM ET

Accepted

Oct 14, 7:09 PM ET

Size

7.8 KB

Accession

0001209191-22-053710

Insider Transaction Report

Form 4
Period: 2022-10-12
Ndu Adora
Director
Transactions
  • Award

    Restricted Stock Units

    2022-10-12+8,7628,762 total
    Common Stock (8,762 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-10-12+14,07714,077 total
    Exercise: $17.12Exp: 2032-10-11Common Stock (14,077 underlying)
Footnotes (3)
  • [F1]The shares subject to the stock option shall vest in two equal annual installments commencing on the first anniversary of the grant date.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
  • [F3]The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date.

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeother

Related Parties

1
  • filerCIK 0001865210

Filing Metadata

Form type
4
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 7:09 PM ET
Size
7.8 KB